临床外科杂志 ›› 2022, Vol. 30 ›› Issue (8): 790-792.doi: 10.3969/j.issn.1005-6483.2022.08.025

• 综述与讲座 • 上一篇    下一篇

泛素-蛋白酶体系统在食管鳞状细胞癌发生发展中的作用

  

  1. 430022 武汉,华中科技大学同济医学院附属协和医院胸外科
  • 收稿日期:2022-07-14 接受日期:2022-07-14 出版日期:2022-08-20 发布日期:2022-08-20
  • 通讯作者: 李劲松,Email:lijinsong67@hotmail.com

Advances of ubiquitin-proteasome system in the development of esophageal squamous cell carcinoma

  1. Department of Thoracic Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
  • Received:2022-07-14 Accepted:2022-07-14 Online:2022-08-20 Published:2022-08-20

摘要: 蛋白酶体是一个多蛋白复合体,能够调节数百个细胞蛋白质的稳定性,涉及几乎所有的细胞过程。大多数情况下,蛋白质必须与泛素分子链相连,才能被蛋白酶体识别和加工。泛素-蛋白酶体系统(ubiquitin-proteasome system,UPS)调控细胞增殖、凋亡、血管生成和运动,这些过程对致癌尤为重要。有证据表明,UPS的改变与恶性肿瘤有关。食管鳞状细胞癌在我国及东南亚地区发病率较高,且治疗预后不理想。我们对UPS在食管鳞状细胞癌发生发展中的作用进行综述。

关键词: 食管鳞状细胞癌, 泛素-蛋白酶体系统

Abstract: The proteasome is a multi-protein complex capable of regulating the stability of hundreds of cellular proteins involved in almost all cellular processes.In most cases,proteins must be linked to a chain of ubiquitin molecules in order to be recognized and processed by the proteasome.The ubiquitin-proteasome system(UPS) regulates cell proliferation,apoptosis,angiogenesis and motility,processes that are particularly important in carcinogenesis.There is growing evidence that alterations in the UPS are associated with malignancy.Esophageal squamous cell carcinoma has a high incidence and a poor treatment prognosis in China and Southeast Asia.Therefore,we summarize the current literature on the involvement of UPS in esophageal squamous cell carcinoma to highlight its role in tumor development and to provide information for the study of therapeutic targets.

Key words: esophageal squamous cell carcinoma, ubiquitin-proteasome system

[1] 马俊杰, 李斌, 陈海泉. 中下段食管鳞癌的“最佳”手术方式[J]. 临床外科杂志, 2021, 29(8): 781-783.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!